Stockscreener 앱 받기
0.6456
7.24%
0.0436
시간 외 거래:
.65
0.0044
+0.68%
전일 마감가:
$0.602
열려 있는:
$0.6294
하루 거래량:
639.09K
Relative Volume:
0.36
시가총액:
$3.36M
수익:
$852.30K
순이익/손실:
$-21.37M
주가수익비율:
-0.0298
EPS:
-21.6981
순현금흐름:
$-19.06M
1주 성능:
-10.08%
1개월 성능:
-35.12%
6개월 성능:
-57.80%
1년 성능:
-96.56%
1일 변동 폭
$0.6125
$0.659
1주일 범위
$0.59
$0.7779
52주 변동 폭
$0.59
$20.00
Geovax Labs Inc Stock (GOVX) Company Profile
명칭
Geovax Labs Inc
전화
678-384-7220
주소
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.6456 | 3.14M | 852.30K | -21.37M | -19.06M | -21.70 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-04-15 | 재확인 | Alliance Global Partners | Buy |
| 2025-04-15 | 재확인 | D. Boral Capital | Buy |
| 2024-11-11 | 개시 | Alliance Global Partners | Buy |
| 2024-07-16 | 개시 | ROTH MKM | Buy |
| 2020-11-19 | 개시 | Maxim Group | Buy |
모두보기
Geovax Labs Inc 주식(GOVX)의 최신 뉴스
Why Is GOVX Stock Falling Today? - Stocktwits
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit - Yahoo Finance
GeoVax (GOVX) Financial Results: The Available Earnings Metric Delivers a Beat at the Close; Price Move: Shares Move 0.86% DownRevenue Estimate Trend - vinanet.vn
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Labs (GOVX): Armistice Capital and Steven Boyd disclose 4.99% stake - Stock Titan
GeoVax Labs (GOVX) holders report 1.59% stake tied to 118,715 warrants - Stock Titan
GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak - Yahoo Finance
GeoVax Labs, Inc. (GOVX) holders cap ownership at 4.99% with warrants - Stock Titan
GOVX: GEO-MVA targets a $1.3B vaccine market gap with expedited approval and scalable U.S. supply - TradingView
GeoVax Labs (GOVX) Dips 3.38% to $0.74, Holding Above Key $0.70 SupportDaily Profile - Vinanet
GeoVax Labs (NASDAQ:GOVX): What Could Today’s program progress and financing needs Update Reveal? - Kalkine Media
GeoVax Labs, Inc. (GOVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
GeoVax targets Q4 phase 3 trial for MVA mpox vaccine with EMA expedited pathway - Proactive financial news
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase - Yahoo Finance
GeoVax Labs (GOVX) Dips 2.07% to $0.75 as Biotech Tests Key SupportConversion Trade - dars.gov.et
Jane Street Group discloses 4.3% GeoVax Labs (GOVX) ownership in updated 13G - Stock Titan
Health preparedness key as biological threats evolve - BioProcess International
GOVX Q2 2026 Earnings: Loss Narrower Than Expected Despite No RevenueBasic EPS Analysis - vinanet.vn
GOVX Q2 2026 Earnings: Narrower-than-Expected Loss of $0.97 Per Share Beats Estimates by 67%Peak Earnings Alert - vinanet.vn
GeoVax Completes Key Milestones for GEO-MVA, Paving Way for Phase 3 Trial - citybuzz -
GeoVax Announces Completion of Key GEO-MVA Development Milestones, Positioning Program for Pivotal Phase 3 Clinical Study - Yahoo Finance
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio - Yahoo Finance
GeoVax Labs (GOVX) Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.97 Per ShareOne-Time Loss Impact - Vinanet
GeoVax Labs Inc (GOVX) Institutional Confidence - TradingKey
GOVX Q2 2026 Earnings: EPS Surprises Positively Despite Revenue AbsenceReturn On Assets - vinanet.vn
GOVX Q2 2026 Earnings: Narrower-than-expected loss highlights cost discipline amid developmental stageRevenue Inflection Point - vinanet.vn
GeoVax Labs (GOVX) Drops 6.82% as Biotech Stock Tests Key Support LevelsTurnaround Stocks - dars.gov.et
GeoVax Labs Inc (GOVX) Valuation: PE, PB & Fair Value Analysis - TradingKey
GeoVax Labs, Inc. 2026 Q2 Financial Report: Earnings, Losses & Key Financial Statements Overview - Minichart
GeoVax Advances GEO-MVA Pivotal Study Amid Strategic Reprioritization - citybuzz -
GeoVax Labs, Inc. Reports Q2 2026 Financial Results and Advances in Immuno-Oncology Programs - Minichart
GEOVAX LABS ($GOVX) Releases Q2 2026 Earnings - Quiver Quantitative
GeoVax Labs Inc reports results for the quarter ended June 30Earnings Summary - TradingView
GeoVax Reports Q2 2026 Net Loss of $4.4 Million - Quiver Quantitative
GeoVax Labs reports Q2 net loss $4.43M, cash ~$3.1M; advances GEO‑MVA pivotal study - TradingView
GeoVax Labs, Inc. 2026: Revenue $0 EPS ($0.97) — 10-Q Summary - TradingView
GeoVax Labs (GOVX) narrows loss but warns on cash runway and Nasdaq risk - Stock Titan
GeoVax Reports Second Quarter 2026 Financial Results and Provides Business Update - TradingView
GeoVax Labs Inc (GOVX) Cash Flow - TradingKey
GeoVax Labs Inc (GOVX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GeoVax Labs Inc (GOVX) Balance Sheet - TradingKey
GeoVax Labs Inc (GOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GOVX Q1 2026 Earnings: Narrowed Loss Beats Estimates Amid No RevenueQuarterly Financial Update - vinanet.vn
GeoVax Labs, Inc. Revenue Breakdown – NASDAQ:GOVX - TradingView
GeoVax Labs (GOVX) Tumbles 13% as Biotech Stock Tests Key Support at $0.69Earnings Breakout Stocks - dars.gov.et
GOVX|GeoVax Labs Inc|Price:0.755|Chg%:+0.024 - TradingKey
GOVX|GeoVax Labs Inc|Price:0.770|Chg%:+0.049 - TradingKey
GeoVax Labs Inc (GOVX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GeoVax Labs Inc (GOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GeoVax Labs Inc (GOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GOVX|GeoVax Labs Inc|Price:0.733|Chg%:-0.107 - TradingKey
Geovax Labs Inc (GOVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
1.07%
자본화:
|
볼륨(24시간):